Wealthfront Advisers’s Repligen RGEN Stock Holding History

Wealthfront Advisers’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,244	Closed	-$330K	–	811
2021 Q4	$330K	Sell	1,244 -363	-23%	-$97.8K	﹤0.01%	660
2021 Q3	$464K	Buy	+1,607	New	+$412K	﹤0.01%	571

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wealthfront Advisers's RGEN Position: Q1 2022 in Review

Wealthfront Advisers sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,244 shares — an estimated $330K sold.

Wealthfront Advisers first reported a position in RGEN in Q3 2021 and held it in 2 quarters. The position peaked at $464K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

Wealthfront Advisers reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
Wealthfront Advisers sold 1,244 Repligen shares in Q1 2022, an estimated $330K.
Wealthfront Advisers first reported a position in Repligen in Q3 2021 and held it in 2 quarters.
Wealthfront Advisers's Repligen position peaked at $464K in Q3 2021.
450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Wealthfront Advisers's 13F filing for Q1 2022, filed 16 May 2022.